Connection

Andrew Kraft to Drug Therapy, Combination

Back to Details
This is a "connection" page, showing publications Andrew Kraft has written about Drug Therapy, Combination.
Andrew Kraft
Connection Strength
0.135
Drug Therapy, Combination
  1. Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset. Oncotarget. 2017 May 02; 8(18):30199-30216.
    View in: PubMed
    Score: 0.120
  2. Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer. BMC Cancer. 2007 Dec 20; 7:231.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.